Evidence map›Paper›PMID 29875738›Full record

ArticleFrontiers in microbiology2018

Identification of Two Lpp20 CD4

Yunshan Ning, Jianbin Ye, Junjie Wen, Danlin Wu, Zhongbiao Chen, Yanqing Lin, Bingxin Hu, Meiqun Luo, Jun Luo, Lijun Ning and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. How Long Will It Take to Launch an EffectiveInfection and drug resistance · 2023
    Review
  3. Virusdisease · 2021
    Article
  4. Notch 1 Is Involved in CD4Frontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yunshan NingSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Jianbin YeSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Junjie WenSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Danlin WuSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Zhongbiao ChenAffiliated Foshan Hospital of Southern Medical University, Foshan, China.
Yanqing LinSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Bingxin HuSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Meiqun LuoSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Jun LuoSchool of Public Health, Southern Medical University, Guangzhou, China.
Lijun NingSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Yan LiSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antigen-specific CD4

Indexed as

CD4+ T cellHelicobacter pyloriHLA restrictionimmunodominant epitopeLpp20

Identifiers

PMID29875738
PMCPMC5974113
OpenAlexW2804512442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.